The metabolic syndrome in Hong Kong Chinese: The interrelationships among its components analyzed by structural equation modeling

Diabetes Care

Volumn 19, Issue 9, 1996, Pages 953-959

  Chan, Juliana C N ^a,b   Cheung, Jacky C K ^c   Lau, Edith M C ^a   Wooà, Jean ^a   Chan, Albert Y W ^b   Swaminathan, Ramasmyiyer ^b   Cockrama, Clive S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; AGING; ARTICLE; BODY MASS; CHINESE; DIABETES MELLITUS; FAMILIAL DISEASE; FEMALE; GLUCOSE INTOLERANCE; HONG KONG; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MODEL; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEINURIA;

EID: 0029741322     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.9.953     Document Type: Article

References (51)

1. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
2. Groop L, Ekstrand A, Forsblom C, Widen E, Groop GH, Teppo AM: Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:642-647, 1993
3. Niskanen L, Laakso M: Insulin resistance is related to albuminuria in type 11 (non-insulin-dependent) diabetes mellitus. Metabolism 12:1541-1545, 1993
4. Nosadini R, Solini A, Velussi M, Muollo B, Frigato F, Sambataro M: Impaired insulin-induced glucose uptake by extrahepatic tissue is a hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes 43:491-499, 1994
5. Cockram CS, Woo J, Lau E, Chan JCN, Chan AYW, Lau J, Swaminathan R, Donnan SPB: The prevalence of diabetes mellitus and impaired glucose tolerance among Hong Kong Chinese adults of working age. Diab Res Clin Pract 21:67-73, 1993
6. Lau E, Woo J, Cockram CS, Chan A, Lam CWK, Swaminathan R, Donnan SPB: Serum lipid profile and its association with some cardiovascular risk factors in an urban Chinese population. Pathology 25: 345-350, 1993
7. Woo J, Cockram CS, Swaminathan R, Lau E, Chan A, Cheung R: Microalbuminuria and other cardiovascular risk factors in nondiabetic subjects. Int J Cardiol 37: 345-350, 1992
8. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M, Ravussin E, Knowler WC, Bennett PH, Howard RV, Borgardus C: Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 324:733-739, 1991
9. Williams B: Insulin resistance: the shape of things to come. Lancet 344:521-524, 1994
10. Donahue RP, Skyler JS, Schneiderman N, Prineas RJ: Hyperinsulinemia and elevated blood pressure: cause, confounder or coincidence. Am J Epidemiol 132:827-836, 1990
11. Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK: Hyperinsulinaemia, upper body adiposity and cardiovascular risk factors in non-diabetics. Metabolism 37: 338-345, 1988
12. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G: Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J 288:1401-1404, 1984
13. Kissebah AH, Peiris AN: Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 5:83-109, 1989
14. Fujioka S, Matsuzawa Y: Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism. Metabolism 36:54-59, 1987
15. Lapidus L, Bengtsson C, Larsson B, Pennen K, Rybo E, Sjostrom L: Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 289:1257-1261, 1984
16. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Tokunaga K: Pathophysiology and pathogenesis of visceral fat obesity. Ann N Y Acad Sci 748:399-406, 1995
17. Vague J: Regulation of the fat mass. In Obesities. Marseille, France, 1991, p. 25-34
18. Björntorp P: Metabolic implications of body fat distribution. Diabetes Care 14: 1132-1143, 1991
19. Rebuffé-Scrive M, Andersson O, Olbe L, Björntorp P: Metabolism of adipose tissue in intraabdominal depots in severely obese men and women. Metabolism 39: 1021-1025, 1990
20. Björntorp P: Fatty acids, hyperinsulinemia, and insulin resistance: which comes first? Girr Opin Lipidology 5:166-174, 1994
21. Randle PJ, Hales CN, Garland PB, Newsholme EA: The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet ii:785-789, 1963
22. Holmâng P, Björntorp P: The effects of cortisol on insulin sensitivity in muscle. Acta Physiol Stand 144:425-431, 1992
23. Saha AK: Lipid abnormalities in tissues of the KKAy mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol. Am J Physiol 267:E95-E101, 1994
24. Gans ROB, Donker JM: Insulin and blood pressure regulation. J Intern Med 229:49-64, 1991
25. Daly PA, Landsberg L: Hypertension in obesity and NIDDM: role of insulin and sympathetic nervous system. Diabetes Care 14:240-248, 1991
26. Ferrannini E, Seghieri G, Muscelli E: Insulin and the renin-angiotensin-aldosterone system: influence of ACE inhibition. J Cardiovax Pharmacol 24 (Suppl. 3):S61-S69, 1994
27. Scholey JW, Meyers TW: Control of glomerular hypertension by insulin administration in diabetic rats. J Clin Invest 83: 1384-1389, 1989
28. Nestler JE, Barlascini CO, Tetrault GA, Fratkin MJ, Clore JN, Blackard WG: Increased transcapillary escape rate of albumin in nondiabetic men in response to hyperinsulinemia. Diabetes 39:1212-1217, 1990
29. Parving HH, Hommel E, Mathiesen R, Skott P, Edsberg B, Bahnsen M, Lauritzen M, Hougaard P, Lauritzen E: Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. BMJ 296:156-160, 1988
30. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the developmem and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
31. Chan MK, Persaud JW, Ramdial L, Varghese Z, Sweny P, Moorhead JF: Hyperlipidaemia in untreated nephrotic syndrome: increased production or decreased removal. Clin Chem Acta 117:317-323, 1981
32. Moorhead JF, Chan MK, El-Nahas M, Varghese Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet ii: 1309-1311, 1982
33. Jöreskog KG, Sörbom D: LISREL 8 User's Reference Guide. Chicago, IL, Scientific Software, 1993
34. Jöreskog KG: Testing structural equation models. In Testing Structural Equation Models. Bollen KA, LongJS, Eds. Newbury Park, CA, Sage, 1993, p. 294-316
35. Schwab SJ, Dunn FL, Feinglos MN: Screening for microalbuminuria. Diabetes Care 15:1581-1584, 1992
36. World Health Organization: Diabetes Mellitus. Report of a WHO Study Croup. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no 727)
37. WHO Expert Committee Report on Arterial Hypertension. Geneva, World Health Org., 1978 (Tech. Rep. Ser., no. 628)
38. Woo J, Lau E, Chan A, Cockram C, Swaminathan R: Blood pressure and urinary cations in a Chinese population. J Hum Hypertens 6:299-304, 1992
39. McGarry JD: What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766-770, 1992
40. Lithell HOL: Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 40:203-209, 1991
41. Gerich JE: Oral hypoglycemic agents. N Engl J Med 321:1231-1245, 1989
42. Porte DJr: Banting Lecture 1990: β-cells in type II diabetes mellitus. Diabetes 40: 166-180, 1991
43. Taylor SI, Accili D, Imai Y: Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes 43:736-740, 1994
44. United Kingdom Prospective Diabetes Study: III. Prevalence of hypertension and hypotensive therapy in patients wtih newly diagnosed diabetes: a muticentre study. Hypertension 7(Suppl. 2):118-1113, 1985
45. Felig P: Disorders of carbohydrate metabolism. In Metabolic Control and Disease. 8th ed. Bondy PK, Rosenberg LE, Eds. Philadelphia, Saunders, 1980, p. 277-301
46. Axelrod J, Reisine TD: Stress hormones: their interaction and regulation. Science 224:452-459, 1984
47. Feldberg W, Pyke DA, Stubbs WA: On the origin of non-insulin-dependent diabetes. Lancet i: 1263-1264, 1985
48. Julius S, Gudbrandsson T, Jamerson K, Andersson O: The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension. Blood Pressure 1:9-19, 1992
49. Guillaume-Gentil C, Assimacopoulos-Jeannet F, Jeaurenaud B: Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in rats. Diobetologia 36:899-906, 1993
50. Björck S, Aurell M: Diabetes mellitus, the renin-angiotensin system and angiotensin-converting enzyme inhibition. Nephron 55:10-20, 1990
51. Newberry BH, Jaikins-Madden JE, Gerstenberger TJ: A Holistic Conceptualization of Stress and Disease. New York, AMS Press, 1991, p. 38-99